Market Closed -
TEL AVIV STOCK EXCHANGE
07:24:09 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
1,283
ILa
|
-3.17%
|
|
-0.62%
|
-9.39%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
657
|
729.3
|
618.8
|
1,461
|
1,997
|
1,499
|
Enterprise Value (EV)
1 |
12,958
|
11,478
|
11,021
|
11,354
|
11,371
|
10,556
|
P/E ratio
|
-0.64
x
|
-0.32
x
|
3.94
x
|
11.4
x
|
13
x
|
8.14
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.07
x
|
0.08
x
|
0.07
x
|
0.17
x
|
0.22
x
|
0.16
x
|
EV / Revenue
|
1.39
x
|
1.29
x
|
1.26
x
|
1.29
x
|
1.27
x
|
1.16
x
|
EV / EBITDA
|
3.96
x
|
4.21
x
|
3.23
x
|
3.32
x
|
3.25
x
|
3.08
x
|
EV / FCF
|
6.98
x
|
17.7
x
|
5.55
x
|
12.8
x
|
7.45
x
|
7.64
x
|
FCF Yield
|
14.3%
|
5.66%
|
18%
|
7.8%
|
13.4%
|
13.1%
|
Price to Book
|
2.88
x
|
-3.9
x
|
-5.78
x
|
91.3
x
|
36.5
x
|
7.92
x
|
Nbr of stocks (in thousands)
|
29,889
|
116,317
|
116,317
|
114,859
|
108,553
|
105,881
|
Reference price
2 |
21.98
|
6.270
|
5.320
|
12.72
|
18.40
|
14.16
|
Announcement Date
|
5/15/19
|
4/23/20
|
3/25/21
|
3/24/22
|
3/15/23
|
3/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
9,321
|
8,929
|
8,723
|
8,821
|
8,986
|
9,103
|
EBITDA
1 |
3,274
|
2,727
|
3,411
|
3,424
|
3,497
|
3,423
|
EBIT
1 |
1,536
|
1,562
|
2,103
|
2,068
|
2,162
|
2,132
|
Operating Margin
|
16.48%
|
17.49%
|
24.11%
|
23.44%
|
24.06%
|
23.42%
|
Earnings before Tax (EBT)
1 |
-1,918
|
92
|
1,234
|
1,378
|
1,227
|
1,400
|
Net income
1 |
-1,029
|
-853
|
157
|
129
|
158
|
187
|
Net margin
|
-11.04%
|
-9.55%
|
1.8%
|
1.46%
|
1.76%
|
2.05%
|
EPS
2 |
-34.44
|
-19.76
|
1.350
|
1.112
|
1.410
|
1.740
|
Free Cash Flow
1 |
1,857
|
649.9
|
1,987
|
885.6
|
1,527
|
1,382
|
FCF margin
|
19.92%
|
7.28%
|
22.78%
|
10.04%
|
17%
|
15.18%
|
FCF Conversion (EBITDA)
|
56.71%
|
23.83%
|
58.26%
|
25.87%
|
43.67%
|
40.38%
|
FCF Conversion (Net income)
|
-
|
-
|
1,265.76%
|
686.53%
|
966.61%
|
739.1%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/15/19
|
4/23/20
|
3/25/21
|
3/24/22
|
3/15/23
|
3/13/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
12,301
|
10,749
|
10,402
|
9,893
|
9,374
|
9,057
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.757
x
|
3.942
x
|
3.05
x
|
2.889
x
|
2.681
x
|
2.646
x
|
Free Cash Flow
1 |
1,857
|
650
|
1,987
|
886
|
1,527
|
1,382
|
ROE (net income / shareholders' equity)
|
-96.6%
|
-491%
|
-16,364%
|
105%
|
52.9%
|
48.5%
|
ROA (Net income/ Total Assets)
|
4.8%
|
5.58%
|
8.34%
|
7.95%
|
8.34%
|
8.27%
|
Assets
1 |
-21,445
|
-15,274
|
1,882
|
1,622
|
1,895
|
2,260
|
Book Value Per Share
2 |
7.630
|
-1.610
|
-0.9200
|
0.1400
|
0.5000
|
1.790
|
Cash Flow per Share
2 |
36.90
|
7.000
|
7.690
|
8.690
|
7.030
|
6.090
|
Capex
1 |
1,216
|
1,095
|
1,133
|
1,328
|
1,353
|
1,333
|
Capex / Sales
|
13.05%
|
12.26%
|
12.99%
|
15.05%
|
15.06%
|
14.64%
|
Announcement Date
|
5/15/19
|
4/23/20
|
3/25/21
|
3/24/22
|
3/15/23
|
3/13/24
|
Last Close Price
12.83
ILS Average target price
16.9
ILS Spread / Average Target +31.72% Consensus |